Gualberto Oquendo-Roman, MD
Physical Medicine & Rehabilitation · Clermont, FLNPI 1093964819
Payments from drug & device makers
Across 18 payments — averaging $27.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$175
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$101
- Protega Pharmaceutials Inc$98
- Boston Scientific$70
- Averitas Pharma Inc.$22
- Pfizer$21
What the payments were for
- Food & beverage$487100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 9 | $175 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $101 |
| Protega Pharmaceutials Inc | 4 | $98 |
| Boston Scientific | 1 | $70 |
| Averitas Pharma Inc. | 1 | $22 |
| Pfizer | 1 | $21 |
How this compares
$487 in reported general payments places this provider in the 65th percentile of 618 physical medicine & rehabilitation providers in Florida.
See all physical medicine & rehabilitation providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 26 | $30,396 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 855 | $29,451 |
| LinzessLinaclotide | 38 | $23,173 |
| Pregabalin | 453 | $15,341 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 587 | $15,077 |
| Oxycodone Hcl | 509 | $9,293 |
| Xtampza ErOxycodone Myristate | 13 | $7,031 |
| Lidocaine | 98 | $6,354 |
| Gabapentin | 431 | $5,105 |
| Diclofenac Sodium | 275 | $4,331 |
| Morphine Sulfate ErMorphine Sulfate | 170 | $3,624 |
| Baclofen | 413 | $3,368 |
| Morphine Sulfate | 110 | $2,955 |
| Tramadol Hcl | 304 | $2,125 |
| Tizanidine Hcl | 224 | $1,877 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Clermont
- Alan MillerFernandina Beach$784K
- Anthony GiuffridaFort Lauderdale$443K
- Paul WuOakland Park$311K
- Marissa McCarthyTampa$239K
- Ryan HafnerSarasota$200K
- Cassandra ListJacksonville$154K
- Benjamin WesterhausMangonia Park$100K
- Michael YuClearwater$47K
- Jose Medina SanchezTampa$30K
- Anish SoniNaples$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.